| |
|
| This news site is not sanctioned by, nor part of, the Diamond Headache Foundation, The American Academy of Neurology OR The American Headache Society. |
| News covering selected sessions related to migraine from 2008 medical conferences. |
|
| |
| 50th Annual Meeting of the American Headache Society |
Boston, Massachusetts June 26-29, 2008 |
|
|
|
|
|
 |
Please select from the following conference coverage topics: |
 |
|
|
|
Harold G. Wolff Lecture Award Recipient Warns Against Medication Overuse
The use of opiates and barbiturates should be well monitored in migraineurs and caution should be advised to individuals with high frequency of headaches who use any medications, said Dr. Marcelo Bigal during his Harold G. Wolff Lecture at the 50th Annual Scientific Meeting of the American Headache Society on June 27.
Headache Care Providers urged to use open-ended Questions
Many physicians fear that asking open-ended questions of patients will significantly increase the length of office visits, but data from the American Migraine Communication Studies (AMCS-I & II) refute that concern, said Dr. Richard B. Lipton at the 50th Annual Scientific Meeting of the American Headache Society on June 29.
International Classification of Headache Proves to be a Crucial Advance
The international classification of headache disorders (ICHD-1 and 2) may be the most important advance in headache science for 50 years, said Dr. Jes Olesen at the 50th Annual Scientific Meeting of the American Headache Society on June 28.
Improved Communication Strategies can Aid Headache Treatment 
The patient, not the clinician, is the authority on pain but clinicians need to realize the pain the patient is experiencing can present a barrier to patient-doctor communication, said Dr. Kathleen Farmer at the 50th Annual Scientific Meeting of the American Headache Society on June 29.
Modulation of Headache Pain
Learning and cognitive changes contribute to the development of chronic pain, which points to the need for early, effective intervention and for an accurate assessment of patients’ expectations to improve, said Dr. Howard L. Fields of the University of California, San Francisco, at the 50th Annual Meeting of the American Headache Society on June 26.
Glial Cells and Pain Control
Glial cells may not only dysregulate pain but they also may dysregulate the actions of opioids as well. In addition, there are now hints that glial cells may be involved in the transition from acute to chronic pain, reported Dr. Linda R. Watkins at the 50th Annual Scientific Meeting of the American Headache Society on June 26.
No evidence-based research supports idiopathic Intracranical Hypertension Treatments
Although no evidence-based therapy exists for the successful treatment of Idiopathic Intracranical Hypertension (IICH), several therapies are in use today that have varied results, according to a presentation by Dr. Deborah Friedman at the 50th Annual Scientific Meeting of the American Headache Society on June 28.
Neurostimulation for Refractory Primary Headache
Occipital nerve stimulation and deep brain stimulation are two promising therapies for patients with intractable refractory headache, said Dr. Peter J. Goadsby on June 27 at the 50th Annual Meeting of the American Headache Society.
Occipital Nerve Stimulation for Refractory Primary Headache
Occipital-nuchal pain in primary headache disorders is very common and almost up to half of all patients with cluster headaches have some amount of pain in the occipital-nuchal region, reported Dr. David W. Dodick of the Mayo Clinic in Phoenix and the president-elect of the American Headache Society during its 50th Annual Meeting on June 27.
|
|
|
|
|
| |
Terms of Use
Privacy Policy
Contact Us
|
| |
| |
Copyright ©2010 Elsevier/International Medical News Group |
|
| |
5635 Fishers Lane, Suite 6000
Rockville, MD 20852
Rights reserved Clinical Neurology News Network |
|
